Oliver_Triebold
Schellenberg Wittmer advised Bioventure Club Deal Nine & Co KG in a Series C financing round of the Swiss Aphaia companies, which are clinical-stage pharmaceutical companies that have developed proprietary treatment methods targeting obesity and related metabolic diseases.
The Schellenberg Wittmer team comprised Oliver Triebold (pictured), Elia Claude Schunck and Seraina Zuber (all corporate / M&A).
Legalcommunity.ch
Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).
For further information, please visit the Group’s website www.lcpublishinggroup.com
SHARE
